Drug Target Review2025-08-29T13:30:59
New research from Gladstone Institutes shows that chronic overactivation of dopamine-producing neurons can directly trigger their death, offering new insights into why these cells deteriorate in Parkinson’s disease which could lead to potential therapies to slow its progression.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-21T09:36:00
Contributor Jayson Uffens, Drug Target Review
2026-06-04T07:05:00
Author Graham Craig
2023-05-23T11:10:47
Sponsored by NanoTemper Technologies
2026-05-26T09:05:00
Contributor Thomas Clozel M.D., Drug Target Review
2023-01-06T10:25:33
Sponsored by Leica Microsystems
2023-05-10T11:18:16
Sponsored by Revvity
Site powered by Webvision Cloud